Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03181100
Title Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors M.D. Anderson Cancer Center
Indications

thyroid gland carcinoma

thyroid gland anaplastic carcinoma

Therapies

Atezolizumab + Cobimetinib

Atezolizumab + Bevacizumab

Atezolizumab + Nab-paclitaxel

Atezolizumab + Cobimetinib + Vemurafenib

Atezolizumab + Paclitaxel

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST